Method Development and Validation of Montelukast in Bulk and Pharmaceutical Dosage form by RP-HPLC

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2012, Vol 1, Issue 2

Abstract

The present work describes a simple, precise and accurate HPLC method for estimation of montelukast sodium in bulk and in tablet dosage form. Montelukast sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene (CysLT1) receptor. The separation was achieved by using Waters symmetry shield RP-C8 column and acetonitrile: sodium di-hydrogen Phosphate dehydrate (pH 3.7) in proportion of 70:30 v/v as mobile phase, at a flow rate of 1.5 ml/min. Detection was carried out at 225 nm. The retention time of montelukast sodium was found to be 3.721 min. The limit of detection was found 0.1357 µg/ml and limit of quantification 0.4111 µg/ml. The accuracy and reliability of the proposed method was ascertained by evaluating various validation parameters like linearity (1-30 µg/ml), accuracy, precision, robustness and specificity according to ICH guidelines. The method was statistically validated and RSD was found to be less than 2% indicating high degree of accuracy and precision of the proposed HPLC method. Due to its simplicity, rapidness, high precision and accuracy, the proposed HPLC method may be used for determining Montelukast in bulk or in pharmaceutical dosage forms.

Authors and Affiliations

Minaketan Sahoo*| Institute of Pharmacy and Technology, Salipur, Cuttack, Odisha, India-754202, B V V Ravi Kumar| Roland institute of pharmaceutical sciences, Berhampur, Ganjam,Odisha, N K Tripathy| Dept. of zoology, Berhampur University, Berhampur, Ganjam, Odisha, India, Saroj Kumar Patro| Institute of Pharmacy and Technology, Salipur, Cuttack, Odisha, India-754202

Keywords

Related Articles

THE ASSOCIATION BETWEEN OSTEOPOROSIS AND CHRONIC PERIODONTITIS: A CASE-CONTROL STUDY

Background & Objectives: Periodontitis and osteoporosis affects millions of people around the world resulting in significant amount of morbidity. This cross-sectional study aims to determine the association between osteo...

The key role of Kefir probiotic in enhancement the therapeutic action of mesenchymal stem cells in LPS- induced liver injury

Acute liver injury occurs after intraperitoneal injection of lipopolysaccharide (LPS). The release of pro-inflammatory cytokines and oxidative stress are both important in the pathogenesis of LPS-induced liver injury. Th...

SURGICAL RELEASE FOR TENNIS ELBOW-A CASE SERIES AT VIMS, BELLARY

OBJECTIVE: To assess the outcome of open release in the management of resistant tennis elbows, based on patient satisfaction. METHODS: This was an observational retrospective case series of 25 consecutive patients that u...

INSOMNIA WITH HOMOEOPATHY

Most people encounter sleep difficulties from time to time, often related to stress or pain. Many of these bouts get better without treatment. Unfortunately, in a significant proportion of the population, sleep problems...

Informed Consent: A Mandatory Step in Clinical Trials.

Voluntary written consent given by potential subjects to participate in a clinical trial is known an informed consent. The informed consent process is designed keeping in mind the safety, benefits and rights of the resea...

Download PDF file
  • EP ID EP1515
  • DOI -
  • Views 620
  • Downloads 30

How To Cite

Minaketan Sahoo*, B V V Ravi Kumar, N K Tripathy, Saroj Kumar Patro (2012). Method Development and Validation of Montelukast in Bulk and Pharmaceutical Dosage form by RP-HPLC. Journal of Biomedical and Pharmaceutical Research, 1(2), 18-26. https://europub.co.uk./articles/-A-1515